Erin S. LeBlanc, MD, MPH

Investigator
Photo of Erin LeBlanc

Dr. Erin LeBlanc is an epidemiologist and board-certified adult endocrinologist. Her research focuses on conditions that affect women, including menopause, obesity, osteoporosis, diabetes, and vitamin D deficiency.

In 2011, Dr. LeBlanc led a systematic evidence review on obesity to support the U.S. Preventive Services Task Force. In 2014, she will lead a systematic evidence review regarding screening for vitamin D. Currently, she is leading a study to examine risk factors associated with fractures among people taking bisphosphonates. The study is comparing people who suffered fractures during bisphosphonate therapy to people who did not, to identify characteristics that may differ.

Dr. LeBlanc is a co-investigator on the Study of Osteoporotic Fractures (SOF), a nearly 30-year-old study that is linking its database with Medicare claims data for nearly 10,000 women to examine relationships between aging and cognitive function, physical performance, bone mineral density, and body weight.

Dr. LeBlanc came to CHR in 2009 from Oregon Health & Science University (OHSU), where she proposed a randomized trial testing the efficacy of vitamin D repletion on body composition in perimenopausal women. She served as the Principal Investigator for the Women’s Health Initiative study, which examined heart disease, cancer, and osteoporosis in postmenopausal women.

Dr. LeBlanc graduated cum laude from the Yale University School of Medicine. Following her internal medicine residency at Stanford University and before joining OHSU, she completed a fellowship in women’s health at the Portland VA Medical Center. She is a member of the Endocrine Society and the American Diabetes Association. She remains an affiliate assistant professor of endocrinology at OHSU.

E-mail: Erin.S.LeBlanc@kpchr.org

Back to Investigators »

Recent Publications

Cheung KL, Stefanick ML, Allison M, LeBlanc ES, Vitolins MZ, Shara NM, Chertow GM, Winkelmayer WC, Tamura MK. Menopausal symptoms in women with chronic kidney disease. Menopause. 2015 Jan 26. [Epub ahead of print]   PubMed abstract
Crandall CJ, Aragaki A, Cauley JA, Manson JE, LeBlanc E, Wallace R, Wactawski-Wende J, LaCroix A, O'Sullivan MJ, Vitolins M, Watts NB. Associations of menopausal vasomotor symptoms with fracture incidence. J Clin Endocrinol Metab 2015 Feb;100(2):524-534 [Epub 2014 Dec 18]   Full text
Funk KL, LeBlanc ES, Vesco KK, Stevens VJ. Woman's attitudes toward a preconception healthy lifestyle program. Clinical Obesity 2015;5(2):67-71. PMID: 25371447. doi: 10.1111/cob.12088  
Funk KL, LeBlanc ES, Vesco KK, Stevens VJ. Women's attitudes towards a pre-conception healthy lifestyle programme. Clin Obes. 2015 Apr;5(2):67-71. doi: 10.1111/cob.12088. Epub 2015 Mar 4.   PubMed abstract
Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton MN, Paris K, Klifa CC, Lasser NL, LeBlanc ES, Shepherd JA, Snetselaar LG, Stanczyk FZ, Stevens VJ, Dorgan JF. Adolescent endogenous sex hormones and breast density in early adulthood. Cancer Epidemiology, Biomarkers & Prevention, 2015; 24(4):762. PMID: 25834159  
LeBlanc ES, Chou R. Vitamin D and falls: fitting new data with current guidelines. JAMA Intern Med. 2015 May 1;175(5):712-3. doi: 10.1001/jamainternmed.2015.0248.   PubMed abstract
LeBlanc ES, Hedlin H, Qin F, Desai M, Wactawski-Wende J, Perrin N, Manson JE, Johnson KC, Masaki K, Tylavsky FA, Stefanick ML. Calcium and vitamin D supplementation do not influence menopause-related symptoms: Results of the Women's Health Initiative Trial. Maturitas. 2015 Jul;81(3):377-83. doi: 10.1016/j.maturitas.2015.04.007. Epub 2015 Jun 1.   Full text
LeBlanc ES, Rosales AG, Kachroo S, Mukherjee J, Funk KL, Schneider JL, Nichols GA. Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes. BMJ Open Diabetes Res Care 2015 Feb 24;3(1):e000062. PMCID: PMC4342519   Full text
LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2015 Jan 20;162(2):109-122.  
Song Y, Huang YT, Song Y, Hevener AL, Ryckman K, Qi L, LeBlanc ES, Kazlauskaite R, Brennan K, Liu S. Birthweight, mediating biomarkers and the development of type 2 diabetes later in life: a prospective study of multi-ethnic women. Diabetologia. 2015 Jun;58(6):1220-30. doi: 10.1007/s00125-014-3479-2. Epub 2015 Jan 8.   PubMed abstract


More Publications »
Kaiser Permanente